Hepatocarcinogenesis associated with hepatitis B, delta and C viruses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatocarcinogenesis associated with hepatitis B, delta and C viruses

Published:2016-10 Issue: Volume:20 Page:1-10
ISSN:1879-6257
Container-title:Current Opinion in Virology
language:en
Short-container-title:Current Opinion in Virology

Author:

Shirvani-Dastgerdi Elham,Schwartz Robert E,Ploss Alexander

Funder

National Institutes of Health

American Cancer Society

Burroughs Wellcome Fund Award

Weill Cornell Center for Advanced Digestive Care

Alice Bohmfalk Charitable Trust

Publisher

Elsevier BV

Subject

Virology

Reference134 articles.

1. Global estimates of cancer prevalence for 27 sites in the adult population in 2008;Bray;Int J Cancer,2013

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Clinical features of hepatitis D;Farci;Semin Liver Dis,2012

4. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study;Buti;J Viral Hepat,2011

5. Hepatitis delta: immunopathogenesis and clinical challenges;Grabowski;Dig Dis,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon;International Journal of Molecular Sciences;2024-06-29

2. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma;Oncology and Translational Medicine;2024-06-03

3. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis;Cancers;2024-04-15

4. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

5. Transcriptomics based identification of S100A3 as the key anti-hepatitis B virus factor of 16F16;Biomedicine & Pharmacotherapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3